Medical warning issued over dangerous height-boosting drug trend among teenagers
AI-generated image
AI Synthesis Sources: 2

Medical warning issued over dangerous height-boosting drug trend among teenagers

A concerning online trend known as "heightmaxxing" has prompted health authorities and medical professionals to issue urgent warnings. Teenagers in Europe and the United States are increasingly experimenting with erdafitinib, a powerful, targeted anti-cancer medication approved for adults with advanced urothelial carcinoma, in an attempt to increase their physical stature. The trend emerged after reports showed that children treated with the drug for brain tumors experienced rapid growth spurts.

Experts, including Cypriot professor of pharmacy Christos Petrou and pediatric endocrinologist Nikos Skordis, highlight the severe dangers of this off-label use. While one case documented a child growing 14.3 centimeters in just nine months, the result was a life-threatening complication requiring surgical intervention. Scientists explain that the drug works by inhibiting specific biological factors that normally regulate bone growth. Misusing this medication does not guarantee a taller adult height but instead risks permanent health damage, including serious genetic complications, leading the European Medicines Agency (EMA) to intervene against this misuse.

Medical experts emphasize that there is no evidence this intervention leads to increased height in adulthood. Instead, the misuse of this potent oncology treatment by healthy adolescents for cosmetic purposes is considered extremely reckless and dangerous.

Original Sources